Status:
COMPLETED
The Efficacy Evaluation of CHOLESWISE Pressed Candy on Cardiovascular Health
Lead Sponsor:
TCI Co., Ltd.
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
To assess the efficacy evaluation of CHOLESWISE Pressed Candy on cardiovascular disease risk factors
Detailed Description
This is a single center, randomized, double-blind and placebo controlled study. Subjects are informed to consume the samples every day for 8 weeks.
Eligibility Criteria
Inclusion
- Age ≥ 30 years old, no gender limit;
- Patients with high blood pressure (systolic blood pressure\> 120 mmHg or diastolic blood pressure\> 80 mmHg) or high blood lipids (TC ≥ 5.18 mmol/L or TG ≥ 1.7 mmol/L), and no medication is used;
- Fully understand the purpose, benefits, potential risks and side effects of this research, and can objectively cooperate with doctors to complete the examination and assessment of diseases and physical conditions;
- People who voluntarily agree and sign an informed consent form.
Exclusion
- People with a history of dyspepsia would affect the absorption of the test product;
- Any situation that may affect trial process, including difficult-to-control organic disease or infection, unstable angina pectoris, congestive heart failure and other severe disease;
- People with symptomatic and difficult-to-control neurological, mental diseases or mental disorders;
- Pregnant or breast-feeding women or women who have a positive result on a pregnancy test;
- Allergic to the components of the test product;
- Take supplementary foods and health supplements with the same efficacy two weeks before and during the test.
Key Trial Info
Start Date :
June 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05182788
Start Date
June 9 2022
End Date
March 31 2023
Last Update
May 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Fengxian District Central Hospital
Shanghai, China, 201499